Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Schorno Dean L (CIK 1509688) reported 14 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-03). Recent activity: Sell RIGL (928 shares), Buy RIGL (694 shares), Buy RIGL (620 shares), Buy RIGL (2,000 shares), Buy RIGL (1,286 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-03 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | Sell | 928 | $44,080 |
| 2026-09-03 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | Buy | 694 | $8,814 |
| 2026-09-03 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | Buy | 620 | $11,594 |
| 2026-09-03 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | Buy | 2,000 | $48,400 |
| 2026-09-03 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | Buy | 1,286 | $31,121 |
| 2026-06-03 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | Buy | 1,200 | $22,440 |
| 2026-06-03 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | Buy | 2,181 | $27,699 |
| 2026-06-03 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | Sell | 928 | $27,710 |
| 2026-02-19 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | Buy | 20,636 | $0 |
| 2026-02-12 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | Sell | 3,546 | $122,763 |
| 2026-02-04 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | Sell | 5,488 | $197,623 |
| 2025-12-29 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | Buy | 1,987 | $39,740 |
| 2025-12-29 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | Buy | 2,846 | $68,873 |
| 2025-12-29 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP & Chief Financial Officer | Buy | 1,667 | $31,173 |
Source: SEC Form 4 filings · as of 2026-09-03